AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Rolandos Enterprises Public LTD

Regulatory Filings Jul 1, 2022

2489_rns_2022-07-01_7ba38c86-9bf7-404c-9a48-dfd9ce258b65.pdf

Regulatory Filings

Open in Viewer

Opens in native device viewer

To:

Cyprus Stock Exchange Nicosia

Attn. to: Mr. Nicos Trypatsas, Acting General Manager of the Cyprus Stock Exchange

July 01, 2022

Subject: Intention to shift the sales of "NEODERMA" products to the Company's subsidiary in The Netherlands

Concerning the above subject matter, we would like to inform you of the following.

After many years of presence and sales of the skincare brand NEODERMA products (the "Products") in the Cypriot market, and considering the development of the optimal performance of the Company's operations and activities on the international market, through its subsidiary company in the Netherlands, NEODERMA AMSTERDAM B.V., the Company has decided to shift the sales operations for its local customers, to its Dutch subsidiary as of the 01/09/2022.

Therefore, the activities of the Company in Cyprus will mainly be related to the export and manufacturing of the NEODERMA products.

We remain at your disposal for any further clarifications.

Yours sincerely,

Rolandos Enterprises niblic limited.

Zoe Loizou Secretary of the Board of Directors Rolandos Enterprises Public Limited

Talk to a Data Expert

Have a question? We'll get back to you promptly.